{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:32:38Z","timestamp":1794461558807,"version":"4.9.1"},"reference-count":39,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2021.0015","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T06:20:21Z","timestamp":1617085221000},"source":"Crossref","is-referenced-by-count":11,"title":["The Interdisciplinary Management of Newly Diagnosed Pituitary Tumors"],"prefix":"10.3238","author":[{"given":"Cornelia","family":"Jaursch-Hancke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich J.","family":"Knappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Saeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Flitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"10.3238\/arztebl.m2021.0015_ref1","doi-asserted-by":"crossref","unstructured":"Maldaner N, Serra C, Tschopp O, Schmid C, Bozinov O, Regli L: Modernes Management von Hypophysenadenomen \u2013 gegenw\u00e4rtiger Stand in Diagnostik, Therapie und Nachsorge. Praxis (Bern 1994) 2018; 107: 825\u201335","DOI":"10.1024\/1661-8157\/a003035"},{"key":"10.3238\/arztebl.m2021.0015_ref2","doi-asserted-by":"crossref","unstructured":"Melmed S: Pathogenesis of pituitary tumors. Nat Rev Endocrinol 2011; 7: 257\u201366","DOI":"10.1038\/nrendo.2011.40"},{"key":"10.3238\/arztebl.m2021.0015_ref3","doi-asserted-by":"crossref","unstructured":"Fernandez A, Karavitaki N, Wass JAH: Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 2010; 72: 377\u201382","DOI":"10.1111\/j.1365-2265.2009.03667.x"},{"key":"10.3238\/arztebl.m2021.0015_ref4","doi-asserted-by":"crossref","unstructured":"Agustsson TT, Baldvinsdottir T, Jonasson JG, et al.: The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study. Eur J Endocrinol 2015; 173: 655\u201364","DOI":"10.1530\/EJE-15-0189"},{"key":"10.3238\/arztebl.m2021.0015_ref5","doi-asserted-by":"crossref","unstructured":"Saeger W, L\u00fcdecke DK, Buchfelder M, Fahlbusch R, Quabbe H-J, Petersenn S: Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 2007; 156: 203\u201316","DOI":"10.1530\/eje.1.02326"},{"key":"10.3238\/arztebl.m2021.0015_ref6","doi-asserted-by":"crossref","unstructured":"Mehta GU, Lonser RR: Management of hormone-secreting pituitary adenomas. Neuro Oncol 2017; 19: 762\u201373","DOI":"10.1093\/neuonc\/now130"},{"key":"10.3238\/arztebl.m2021.0015_ref7","doi-asserted-by":"crossref","unstructured":"Vasilev V, Rostomyan L, Daly AF, et al.: Management of endocrine disease: pituitary, incidentaloma\u2018: neuroradiological assessment and differential diagnosis. Eur J Endocrinol 2016; 175: R171\u201384","DOI":"10.1530\/EJE-15-1272"},{"key":"10.3238\/arztebl.m2021.0015_ref8","doi-asserted-by":"crossref","unstructured":"Freda PU, Beckers AM, Katznelson L, et al.: Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 894\u2013904","DOI":"10.1210\/jc.2010-1048"},{"key":"10.3238\/arztebl.m2021.0015_ref9","doi-asserted-by":"crossref","unstructured":"Molitch ME: Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 2009; 23: 667\u201375","DOI":"10.1016\/j.beem.2009.05.001"},{"key":"10.3238\/arztebl.m2021.0015_ref10","doi-asserted-by":"crossref","unstructured":"Karavitaki N: Prevalence and incidence of pituitary adenomas. Ann Endocrinol (Paris) 2012; 73: 79\u201380","DOI":"10.1016\/j.ando.2012.03.039"},{"key":"10.3238\/arztebl.m2021.0015_ref11","doi-asserted-by":"crossref","unstructured":"Brue T, Castinetti F: The risks of overlooking the diagnosis of secreting pituitary adenomas. Orphanet J Rare Dis 2016; 11: 135","DOI":"10.1186\/s13023-016-0516-x"},{"key":"10.3238\/arztebl.m2021.0015_ref12","doi-asserted-by":"crossref","unstructured":"Kane LA, Leinung MC, Scheithauer BW, et al.: Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 1994; 79: 1135\u201340","DOI":"10.1210\/jcem.79.4.7525627"},{"key":"10.3238\/arztebl.m2021.0015_ref13","doi-asserted-by":"crossref","unstructured":"Rubinstein G, Osswald A, Hoster E, et al.: Time to diagnosis in cushing\u2018s syndrome: a meta-analysis based on 5367 patients. J Clin Endocrinol Metab 2020; 105: dgz136. doi: 10.1210\/clinem\/dgz136","DOI":"10.1210\/clinem\/dgz136"},{"key":"10.3238\/arztebl.m2021.0015_ref14","unstructured":"Klingm\u00fcller D, Saller B, Quabbe H-J: Diagnostik von Hyphysenadenomen. Dtsch Arztebl 2001; 98: 3053\u20139"},{"key":"10.3238\/arztebl.m2021.0015_ref15","doi-asserted-by":"crossref","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS: Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 2020; 182: 523\u201331","DOI":"10.1530\/EJE-20-0019"},{"key":"10.3238\/arztebl.m2021.0015_ref16","doi-asserted-by":"crossref","unstructured":"Esposito D, Olsson DS, Ragnarsson O, Buchfelder M, Skoglund T, Johannsson G: Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary 2019; 22: 422\u201334","DOI":"10.1007\/s11102-019-00960-0"},{"key":"10.3238\/arztebl.m2021.0015_ref17","doi-asserted-by":"crossref","unstructured":"Boguszewski CL, Castro Musolino NR de, Kasuki L: Management of pituitary incidentaloma. Best Pract Res Clin Endocrinol Metab 2019; 33: 101268","DOI":"10.1016\/j.beem.2019.04.002"},{"key":"10.3238\/arztebl.m2021.0015_ref18","unstructured":"AWMF: Diagnostik und Therapie klinisch hormoninaktiver S2k Leitlinie Hypophysentumoren Registernummer 089 \u2013 002 19.12.2019. www.awmf.org\/leitlinien\/detail\/ll\/089\u2013002.htm (last accessed on 15 January 2021)."},{"key":"10.3238\/arztebl.m2021.0015_ref19","doi-asserted-by":"crossref","unstructured":"Feldkamp J, Santen R, Harms E, Aulich A, M\u00f6dder U, Scherbaum WA: Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas\u2014results of a prospective study. Clin Endocrinol (Oxf) 1999; 51: 109\u201313","DOI":"10.1046\/j.1365-2265.1999.00748.x"},{"key":"10.3238\/arztebl.m2021.0015_ref20","doi-asserted-by":"crossref","unstructured":"Krikorian A, Aron D: Evaluation and management of pituitary incidentalomas\u2014revisiting an acquaintance. Nat Clin Pract Endocrinol Metab 2006; 2: 138\u201345","DOI":"10.1038\/ncpendmet0122"},{"key":"10.3238\/arztebl.m2021.0015_ref21","doi-asserted-by":"crossref","unstructured":"Fleseriu M, Bodach ME, Tumialan LM, et al.: Congress of neurological surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 2016; 79: E527\u20139","DOI":"10.1227\/NEU.0000000000001387"},{"key":"10.3238\/arztebl.m2021.0015_ref22","doi-asserted-by":"crossref","unstructured":"Molitch ME: Nonfunctioning pituitary tumors. Handb Clin Neurol 2014; 124: 167\u201384","DOI":"10.1016\/B978-0-444-59602-4.00012-5"},{"key":"10.3238\/arztebl.m2021.0015_ref23","doi-asserted-by":"crossref","unstructured":"Ntali G, Wass JA: Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 2018; 21: 111\u20138","DOI":"10.1007\/s11102-018-0869-3"},{"key":"10.3238\/arztebl.m2021.0015_ref24","unstructured":"Kulkarni MV, Lee KF, McArdle CB, Yeakley JW, Haar FL: 1.5-T MR imaging of pituitary microadenomas: technical considerations and CT correlation. AJNR Am J Neuroradiol 1988; 9: 5\u201311."},{"key":"10.3238\/arztebl.m2021.0015_ref25","doi-asserted-by":"crossref","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, et al.: Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 2006; 65: 265\u201373","DOI":"10.1111\/j.1365-2265.2006.02562.x"},{"key":"10.3238\/arztebl.m2021.0015_ref26","doi-asserted-by":"crossref","unstructured":"Melmed S, Casanueva FF, Hoffman AR, et al.: Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 273\u201388","DOI":"10.1210\/jc.2010-1692"},{"key":"10.3238\/arztebl.m2021.0015_ref27","doi-asserted-by":"crossref","unstructured":"Soto-Pedre E, Newey PJ, Bevan JS, Leese GP: Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study. Endocr Connect 2017; 6: 580\u20138","DOI":"10.1530\/EC-17-0171"},{"key":"10.3238\/arztebl.m2021.0015_ref28","doi-asserted-by":"crossref","unstructured":"\u00d3nnestam L, Berinder K, Burman P, et al.: National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab 2013; 98: 626\u201335","DOI":"10.1210\/jc.2012-3362"},{"key":"10.3238\/arztebl.m2021.0015_ref29","doi-asserted-by":"crossref","unstructured":"Deutschbein T, Unger N, Mann K, Petersenn S: Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test. Eur J Endocrinol 2009; 160: 9\u201316","DOI":"10.1530\/EJE-08-0600"},{"key":"10.3238\/arztebl.m2021.0015_ref30","unstructured":"Petersenn S, et al. (eds.): Erkrankungen von Hypothalamus und Hypophyse. Bremen, London, Boston: UNI-MED Verlag 2019."},{"key":"10.3238\/arztebl.m2021.0015_ref31","doi-asserted-by":"crossref","unstructured":"Fahie-Wilson M, Smith TP: Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab 2013; 27: 725\u201342","DOI":"10.1016\/j.beem.2013.07.002"},{"key":"10.3238\/arztebl.m2021.0015_ref32","doi-asserted-by":"crossref","unstructured":"Overgaard M, Pedersen SM: Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia. Clin Chem Lab Med 2017; 55: 1744\u201353","DOI":"10.1515\/cclm-2016-0902"},{"key":"10.3238\/arztebl.m2021.0015_ref33","doi-asserted-by":"crossref","unstructured":"Bhasin S, Brito JP, Cunningham GR, et al.: Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2018; 103: 1715\u201344","DOI":"10.1210\/jc.2018-00229"},{"key":"10.3238\/arztebl.m2021.0015_ref34","unstructured":"Rote-Hand-Brief zu biotinhaltigen Arzneimitteln: Risiko falscher Ergebnisse von Laboruntersuchungen durch Biotininterferenzen 2019, 15 May 2019. www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2019\/rhb-biotin.html (last accessed on 15 January 2021)."},{"key":"10.3238\/arztebl.m2021.0015_ref35","doi-asserted-by":"crossref","unstructured":"Abouaf L, Vighetto A, Lebas M: Neuro-ophthalmologic exploration in non-functioning pituitary adenoma. Ann Endocrinol (Paris) 2015; 76: 210\u20139","DOI":"10.1016\/j.ando.2015.04.006"},{"key":"10.3238\/arztebl.m2021.0015_ref36","doi-asserted-by":"crossref","unstructured":"Donovan LE, Corenblum B: The natural history of the pituitary incidentaloma. Arch Intern Med 1995; 155: 181\u20133","DOI":"10.1001\/archinte.155.2.181"},{"key":"10.3238\/arztebl.m2021.0015_ref37","unstructured":"Lake MG, Krook LS, Cruz SV: Pituitary adenomas: an overview. Am Fam Physician 2013; 88: 319\u201327."},{"key":"10.3238\/arztebl.m2021.0015_ref38","doi-asserted-by":"crossref","unstructured":"Melmed S, Bronstein MD, Chanson P, et al.: A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 2018; 14: 552\u201361","DOI":"10.1038\/s41574-018-0058-5"},{"key":"10.3238\/arztebl.m2021.0015_ref39","doi-asserted-by":"crossref","unstructured":"Burger-Stritt S, Eff A, Quinkler M, et al.: Standardised patient education in adrenal insufficiency: a prospective multi-centre evaluation. Eur J Endocrinol 2020; 183: 119\u201327","DOI":"10.1530\/EJE-20-0181"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T09:42:29Z","timestamp":1638783749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2021.0015","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]}}}